Anika Therapeutics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (19)

Latest Posts

About This Stock More About This Stock
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Article By: Arpita Dutt
Monday, July 17, 2017 11:35 AM EDT
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
Anika Therapeutics Offers A Long-Term Growth Opportunity With Robust Pipeline
Article By: KKD Healthcare Analytics
Wednesday, July 5, 2017 10:43 AM EDT
Anika Therapeutics has relatively mild risk profile. The company has established products in the market while its drug candidates have high probability of receiving the FDA approval as well as of performing well in the market.
In this article: ANIK
Read
Is Economic Growth Slowing – Is This Bull Market About To End?
Article By: Robert Maltbie
Saturday, May 13, 2017 6:51 PM EDT
US economic growth was expected to improve in 2017 but the initial release of the first quarter GDP was less than stellar. And bond yields declined recently – is this a forewarning of a weaker economy and what are the impacts on the equity markets?
In this article: SA, ARTX, GASS, HBIO, IRIX, LABL, STMP, ANIK, CNTY, CTRL
Read
Trend Following Watch List Stocks For This Coming Week
Article By: Andy Abraham
Monday, July 4, 2016 3:20 AM EDT
Every weekend I compile a list of stocks worth watching in my "trend following". However you need to make your own judgement and risk calculations.
In this article: AHS, COR, NSP, TDG, TRRU, STS, ALGN, SIMO, ANIK, BECN, NTES, NVDA, POOL, ULTA, WB, GIMO, PAYC, FCPT, FIVE
Read
GlaxoSmithKline Q1 Earnings Lag, Revenues Up Y/Y
Article By: Zacks Investment Research
Thursday, April 28, 2016 8:30 PM EDT
GlaxoSmithKline PLC reported first-quarter 2016 core earnings of 57 cents per American Depositary Share (ADS), missing the Zacks Consensus Estimate of 60 cents. Nevertheless, the company’s shares inched up 1.8% following the news.
In this article: EBS, GSK, NVS, ANIK
Read

PARTNER HEADLINES

Latest Tweets for $ANIK

No tweets yet!